Use of cytochrome P450 and prolonged prothrombin time.
Liu
A C
AC
D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism* / Q000627:therapeutic use*; D004347:Drug Interactions; D005473:Fluoxetine / Q000493:pharmacokinetics; D006801:Humans; D019934:International Normalized Ratio; D010089:Oxidoreductases, N-Demethylating / Q000378:metabolism; D011517:Prothrombin Time; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics; D039181:Steroid 16-alpha-Hydroxylase; D013250:Steroid Hydroxylases / Q000378:metabolism
D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System; D005473:Fluoxetine; D010089:Oxidoreductases, N-Demethylating; D017367:Selective Serotonin Reuptake Inhibitors; D039181:Steroid 16-alpha-Hydroxylase; D013250:Steroid Hydroxylases